Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder

被引:164
作者
Baker, DG
Ekhator, NN
Kasckow, JW
Hill, KK
Zoumakis, E
Dashevsky, BA
Chrousos, GP
Geracioti, TD
机构
[1] Vet Affairs Med Ctr, Psychiat Serv, PTSD Unit 7E, Cincinnati, OH 45220 USA
[2] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH USA
[3] NICHHD, Pediat & Reprod Endocrinol Branch, NIH, Bethesda, MD USA
关键词
cerebrospinal fluid; cytokines; interleukin-6; hypothalamic-pituitary-adrenocortical axis; posttraumatic stress disorder; cortisol; corticotropin-releasing hormone; norepinephrine; adrenocorticotropin;
D O I
10.1159/000049028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Interleukin-6 (IL-6) secretion is suppressed by glucocorticoids and stimulated by catecholamines. Patients with posttraumatic stress disorder (PTSD) have decreased cortisol and increased catecholamine secretion. The purpose of this study was to assess the relation of IL-6 levels and hypothalamic-pituitary-adrenal and noradrenergic activity in patients with well-characterized PTSD. Methods: Cerebrospinal fluid (CSF) was withdrawn via a lumbar subarachnoid catheter over 6 h from 11 combat veterans with PTSD and 8 age- and sex-matched healthy controls. Blood was withdrawn concurrently. We measured IL-6, CRH and norepinephrine concentrations in the CSF and IL-6, ACTH, cortisol and norepinephrine in plasma. Results: Mean and median CSF IL-6 concentrations were higher in PTSD than in controls (mean = 24.0 vs. 14.6, p = 0.05; median = 26.7 vs. 14.3, p < 0.03): plasma IL-6 concentrations, however, were not different between the two groups. Plasma IL-6 and norepinephrine were positively correlated in the PTSD group (r= +0.74, p < 0.04), but not in normals (r = -0.55, p = 0.20). Conclusions: PTSD patients have increased CSF concentrations of IL-6. Their plasma IL-6 is not elevated but is more tightly associated with noradrenergic output in these patients than in normals. Both findings might be explained by the low cortisol secretion previously reported in PTSD as a result of lowered glucocorticoid suppression of IL-6 secretion. High levels of CSF IL-6 may reflect neurodegeneration or compensatory neuroprotection. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:209 / 217
页数:9
相关论文
共 127 条
[21]  
Bremner JD, 1997, AM J PSYCHIAT, V154, P624
[22]  
Carlson NG, 1999, J IMMUNOL, V163, P3963
[23]   Biological variation of interleukin 6 (IL-6) and soluble interleukin 2 receptor (sIL2r) in serum of healthy individuals [J].
Cava, F ;
González, C ;
Pascual, MJ ;
Navajo, JA ;
González-Buitrago, JM .
CYTOKINE, 2000, 12 (09) :1423-1425
[24]   Clearance of I-125-labeled interleukin-6 from brain into blood following intracerebroventricular injection in rats [J].
Chen, GJ ;
Castro, WL ;
Chow, HH ;
Reichlin, S .
ENDOCRINOLOGY, 1997, 138 (11) :4830-4836
[25]   Blood interleukin-6 and tumor necrosis factor-α elevation after Intracerebroventricular injection of Escherichia coli endotoxin in the rat is determined by two opposing factors:: Peripheral induction by LPS transferred from brain to blood and inhibition of peripheral response by a brain-mediated mechanism [J].
Chen, GJ ;
McCuskey, RS ;
Reichlin, S .
NEUROIMMUNOMODULATION, 2000, 8 (02) :59-69
[26]   SEMINARS IN MEDICINE OF THE BETH-ISRAEL-HOSPITAL, BOSTON - THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS AND IMMUNE-MEDIATED INFLAMMATION [J].
CHROUSOS, GP .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1351-1362
[27]   An assessment of the effects of central interleukin-1β, -2, -6, and tumor necrosis factor-α administration on some behavioural, neurochemical, endocrine and immune parameters in the rat [J].
Connor, TJ ;
Song, C ;
Leonard, BE ;
Merali, Z ;
Anisman, H .
NEUROSCIENCE, 1998, 84 (03) :923-933
[28]   Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis [J].
Crofford, LJ ;
Kalogeras, KT ;
Mastorakos, G ;
Magiakou, MA ;
Wells, J ;
Kanik, KS ;
Gold, PW ;
Chrousos, GP ;
Wilder, RL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (04) :1279-1283
[29]   Interleukin-6 inhibits neurotransmitter release and the spread of excitation in the rat cerebral cortex [J].
D'Arcangelo, G ;
Tancredi, V ;
Onofri, F ;
D'Antuono, M ;
Giovedì, S ;
Benfenati, F .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (04) :1241-1252
[30]  
DAYNES RA, 1993, J IMMUNOL, V150, P5219